Summary
Three hundred sixty Sprague-Dawley rats were allocated into four groups, according to different content of a 24-h iv infusion performed 1 h after intrabiliary injection of enterokinase/sodium taurocholate to induce acute pancreatitis (AP): (1) Saline; (2) 5 μg/kg/h nafamostat mesilate (FUT-175); (3) 10 μg/kg/h FUT-175; and (4) 25 μg/kg/h FUT-175. Peritoneal fluid was removed and exchanged with 1 mL 3.33Mfluorescein-isothiocyanate-conjugated (FITC) dextrans of 4000-40,000 Dalton. Serial blood samples were withdrawn and examined for FITC-dextrans, phospholipase A2 (PLA2), blood gases, amylase, and lipase. As compared to control (55%), FUT-175 brought about a lower(5 μg/kg/h: 25%) or no mortality (10 and 25 μg/kg/h), and a milder histological and biochemical evidence of AP. Untreated animals with PLA2 values over two times the standard deviation showed a respiratory distress. Further, unlike group 1, FUT-175 doses as low as 5 μg/kg prevented the increase in peritoneal permeability to small-size molecules (up to 20,000 Dalton). In a second experiment under the same drug protocol, 1000 U/mL of PLA2 and 2 mL of pancreatitis ascites were instilled ip. Peritoneal permeability to FITC-dextrans up to 30,000 Dalton and to PLA2 significantly increased in the saline group and in the 5 μg/kg FUT-175 group. However, 10 μg/kg and 25 μg/kg FUT-175 doses prevented such phenomenon. In conclusion, FUT-175 proves to be a potent antiprotease molecule with a biochemical activity also against PLA2 in vivo and prevents significant transperitoneal-blood access of pancreatic enzymes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Geokas MC, Rinderknecht H, Brodrick JW, Largman C. Studies on the ascites fluid of acute pancreatitis in man.Am J Dig Dis 1978; 23: 182–188.
McMahon MJ, Playforth MJ, Pickford IR. A comparativestudy of methods for the prediction of severity of acutepancreatitis.Br J Surg 1980; 67: 22–25.
McMahon MJ, Pickford IR, Playforth MJ. Early predictionof severity of acute pancreatitis using peritoneal lavage.Acta Chir Scand 1980; 146: 171–175.
Egdah RH. Mechanism of blood enzyme changes followingthe production of experimental pancreatitis.Ann Surg 1958; 148: 389–400.
Waterman NG, Walsky RS. Transperitoneal absorption ofamylase in acute experimental pancreatitis.Surg GynecolObstet 1970; 131: 729–932.
Sugimoto Y, Hayakawa T, Kondo T, Shibata T, Kishimoto W. Peritoneal absorption of pancreatic enzymes in bileinduced acute pancreatitis in dogs.J Gastroenterol Hepatol 1990; 5: 493–498.
Mayer AD, Airey M, Hodgson J, McMahon MJ. Enzymetransfer from pancreas to plasma during acute pancreatitis.The contribution of ascitic fluid and lymphatic drainage ofthe pancreas.Gut 1985; 26: 876–881.
Lange JF, Beyaert PJ, van Vugt H, Tytgat GNJ, van Gool J. Pathways of enzyme transfer in sodium taurocholateinduced acute hemorrhagic pancreatitis.Digestion 1986; 305: 229–236.
Svensson C, Sjodahl R, Lilja I, Ihse I. The role of ascites andphospholipase A2 on peritoneal permeability changes in acuteexperimental pancreatitis.Int J P ancre atol 1990; 6: 71–79.
Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S, Fujita M. Pharmacological studies of FUT-175,Nafamstat Mesilate. Inhibition of protease activity in invitro and in vivo experiments.Jpn J Pharmacol 1984; 36: 203–227.
Walker WS, Demus A. Antibody-dependent cytolysis ofchicken erythrocytes by an in vitro-established line of mouseperitoneal macrophage.J Immunol 1975; 114: 765–769.
Aho HJ, Koskensalo SM-L, Nevalainen TJ. Experimentalpancreatitis in the rat: sodium taurocholate-induced acutehemorrhagic pancreatitis.Scand J Gastroenterol 1980; 15:411–416.
Rick W, Stegbauer HP. Alpha-Amylase: Messung derreduzierenden Gruppen, inMethoden der enzymatischenanalyse. Verlag Chemie, Weinheim, 1970: pp. 848–853.
Bird NC. A new method for measuring pancreatic phospholipase A2.Clin Chim Acta 1982; 125: 359–365.
Erlanger BF, Kokowsky N, Cohen W. The preparation andproperties of two new chromogenic substrates of trypsin.Arch Biochem 1961; 95: 271–278.
Mashford ML, Roberts ML. Determination of humanurinary kinin levels by radioimmunoassay using a tyrosineanalogue.Biochem Pharmacol 1971; 20: 969–973.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Proteinmeasurement with the folin phenol reagent.J Biol Chem 1951; 193: 265–275.
Paquin J, Benjanmet S, Sawyer N, Lazure C, Chretien M,Seidah NG. Rat plasma kallikrein: purification, NH2-terminal sequencing and development of a specific radioimmunoassay.Biochem Biophys Acta 1989; 999: 103–110.
Spormann H, Sokolowski A, Letko G. Experimental acutepancreatitis: A quantification of dynamics at enzymic andhistomorphological levels.Pathol Res Pract 1989; 185: 358–362.
Ellison EC, Pappas TN, Johnson JA, Fabri PJ, Carey LC. Demonstration and characterization of the hemoconcentrating effect of ascitic fluid that accumulates during hemorrhagic pancreatitis.J Surg Res 1981; 30: 241–248.
Frey CF, Wong HN, Hickman D, Pullo T. Toxicity ofhemorrhagic ascitic fluid associated with hemorrhagicpancreatitis.Arch Surg 1982; 117: 401–404.
Coticchia JM, Lassler MA, Carey LC, Gower WR, Mayer AD, McMahon MJ. Peritoneal fluid in human acute pancreatitis blocks hepatic mitochondrial respiration.Surgery 1986; 100: 850–856.
Etoh Y, Sumi H, Tsushima H, Maruyama M, Mihara H. Fibrinolytic enzymes in ascites during experimental acutepancreatitis in rats.Int J Pancreatol 1992; 12: 127–137.
Foitzik T., Fernandez de Castillo C, Rattner DW, Ferraro MJ, Warshaw AL. Imipenem reduces pancreatic infectionin acute necrotizing pancreatitis in the rat.Pancreas 1993; 8: 755.
Wisner JR, Ozawa S, Renner IG. The effect of NafamostatMesilate (FUT-175) on caerulein-induced acute pancreatitisin the rat.Int J Pancreatol 1989; 4: 383–390.
Manabe T, Hirano T, Imanishi K, Ando K, Yotsumoto F, Tobe T. Protective effect of nafamostat mesilate on cellularand lysosomal fragility of acinar cells in rat caeruleinpancreatitis.Int J Pancreatol 1992; 12: 167–172.
Marotta F, Chui DH, Suzuki K. Is the addition of NafamostatMesilate to peritoneal lavage of any benefit in lethal acutepancreatitis in mice? XXII European Pancreatic Club Meeting, October 15-17,1991, Basel, Switzerland. Digestion 1991; 46: 158.
Taguchi S, Watanabe Y, Usui M, Nakano I, Shigeo S. Anew attempt for the treatment of acute pancreatitis byintraperitoneal single injection of protease inhibitor in dogs.The Pancreas (Tokyo) 1986; 1: 44–54 (in Japanese).
Buchler M, Friess H, Uhl W, Beger HG. Clinical relevanceof experimental acute pancreatitis.Eur Surg Res 1992; 24 (suppl. 1): 85–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marotta, F., Fesce, E., Rezakovic, I. et al. Nafamostat mesilate on the course of acute pancreatitis. Int. J. Pancreatol. 16, 51–59 (1994). https://doi.org/10.1007/BF02925610
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02925610